Moderna
MRNA
#1365
Rank
$13.21 B
Marketcap
$34.17
Share price
4.62%
Change (1 day)
-69.04%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Operating Margin for Moderna (MRNA)

Operating Margin as of March 2025 (TTM): -112.00%

According to Moderna 's latest financial reports and stock price the company's current Operating Margin is -112.00%. At the end of 2024 the company had an Operating Margin of -112.75%.

Operating Margin history for Moderna from 2018 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-112.75%93.19%
2023-58.37%-215.05%
202250.73%-32.28%
202174.90%-127.59%
2020-271.53%-74.69%
2019-1,072.92%241.94%
2018-313.77%116.92%
2017-144.65%-31.74%
2016-211.91%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-118.00% 5.36%๐Ÿ‡บ๐Ÿ‡ธ USA
31.06%-127.73%๐Ÿ‡บ๐Ÿ‡ธ USA
-1,576.98% 1,308.02%๐Ÿ‡บ๐Ÿ‡ธ USA
-16.78%-85.02%๐Ÿ‡บ๐Ÿ‡ธ USA
26.37%-123.54%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-17,247.50% 15,299.55%๐Ÿ‡บ๐Ÿ‡ธ USA
18.78%-116.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-61.01%-45.53%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.